Berger, V.W. ( 2005). Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials. Biometrical Journal, 47, 119-127.
2.
Berger, V.W. ( 2009). A fatally flawed trial. Annals of Internal Medicine. First published online, March 16, 2009, http://www.annals.org/content/150/4/255.abstract/reply.
3.
Berger, V.W., & Alperson, S.Y. (2009). A general framework for the evaluation of clinical trial quality. Reviews on Recent Clinical Trials, 4, 79-88.
4.
Berger, V.W., & Bears, J.D. ( 2003). When can a clinical trial be called ‘randomized’ ? Vaccine, 21, 468-472.
5.
Berger, V.W., Lunneborg, C.E., Ernst, M.D., & Levine, J.G. ( 2002). Parametric analyses in randomized clinical trials. Journal of Modern Applied Statistical Methods, 1, 74-82.
6.
Emons, W. ( 1997). Credence goods and fraudulent experts. RAND Journal of Economics, 28, 107-119.
7.
Gugiu, P.C., & Gugiu, M.R. ( 2010). A critical appraisal of standard guidelines for grading levels of evidence. Evaluation & the Health Professions , 33, 233-255.
